Results 51 to 60 of about 61,494 (68)

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside

Journal of Hematology and Oncology, 2009
Jianbiao Zhou
exaly  

Reexamination of the A.D. 869 Jogan earthquake size from tsunami deposit distribution, simulated flow depth, and velocity

Geophysical Research Letters, 2014
Yuichi Namegaya, Kenji Satake
exaly  

Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer

Journal of Thoracic Oncology, 2011
Ravi Salgia, Benjamin Besse, James Chih-Hsin Yang   +2 more
exaly  

Use of CK-548 and CK-869 as Arp2/3 complex inhibitors directly suppresses microtubule assembly both in vitro and in vivo

Biochemical and Biophysical Research Communications, 2018
Akira Matsuura
exaly  

Assessing the magnitude of the 869 Jogan tsunami using sedimentary deposits: Prediction and consequence of the 2011 Tohoku-oki tsunami

Sedimentary Geology, 2012
Daisuke Sugawara, Kazuhisa Goto, Fumihiko Imamura   +2 more
exaly  

Small Molecules CK-666 and CK-869 Inhibit Actin-Related Protein 2/3 Complex by Blocking an Activating Conformational Change

Chemistry and Biology, 2013
Byron Hetrick, Brad J Nolen
exaly  

OSL dating of the AD 869 Jogan tsunami deposit, northeastern Japan

Quaternary Geochronology, 2015
Toru Tamura, Yuki Sawai, Kazumi Ito
exaly  

Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors

Molecular Cancer, 2010
Yoshifumi Baba, Curtis Huttenhower, Noriko Tanaka   +2 more
exaly  

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869

Cancer, 2002
Myo Thant, Alexandra D Carides
exaly  

Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure

European Journal of Cancer, 2011
Nizar M Tannir, Leonard J Appleman, Neeraj Gupta   +2 more
exaly